Akebia Therapeutics (AKBA) Return on Sales (2017 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Return on Sales of 0.0% for Q1 2026, little changed year-over-year from 0.0% in Q1 2025, and up 20.42% quarter-over-quarter from 0.0% in Q4 2025.
Akebia Therapeutics (AKBA) Return on Sales (2017 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Return on Sales for 10 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Sales advanced to 0.0% in Q1 2026 per AKBA's latest filing, from 0.0% in the prior quarter.
- Across five years, Return on Sales topped out at 0.0% in Q2 2022 and bottomed at 8.19% in Q1 2022.
- Historically, Return on Sales has averaged 0.48% across 5 years, with a median of 0.0% in 2023.
- Annual changes were most pronounced in 2022 — Return on Sales tumbled 818 bps — and 2023, when it soared 819 bps.
- Akebia Therapeutics' Return on Sales stood at 0.0% in 2022, then jumped by 115 bps to 0.0% in 2023, then slumped by 4589 bps to 0.0% in 2024, then surged by 57 bps to 0.0% in 2025, then increased by 20 bps to 0.0% in 2026.
- Business Quant data shows AKBA's Return on Sales at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 0.00% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 0.00% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 0.00% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Akebia Therapeutics | 244.72 Mn | 89.17 Mn | 38.70 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | -8.19% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | -0.01% |